Cell-autonomous and non-cell-autonomous drivers of dopamine neuron vulnerability in Parkinson’s disease
Open Access
- 12 March 2026
- journal article
- review article
- Published by Elsevier in Trends in Neurosciences
- Vol. 49 (5) , 328-343
Abstract
No abstract availableKeywords
Funding Information
- Canadian Institutes of Health Research
- Krembil Foundation
- Aligning Science Across Parkinson's (000525)
This publication has 166 references indexed in Scilit:
- Loss of the lysosomal lipid flippase ATP10B leads to progressive dopaminergic neurodegeneration and parkinsonian motor deficitsActa Neuropathologica, 2025
- The Intricate Interplay: Microbial Metabolites and the Gut‐Liver‐Brain Axis in Parkinson's DiseaseJournal of Neuroscience Research, 2025
- Trafficking of the glutamate transporter is impaired in LRRK2-related Parkinson’s diseaseActa Neuropathologica, 2022
- Parkin Deficiency Impairs Mitochondrial DNA Dynamics and Propagates InflammationMovement Disorders, 2022
- Age-associated insolubility of parkin in human midbrain is linked to redox balance and sequestration of reactive dopamine metabolitesActa Neuropathologica, 2021
- Benefits of Iron Chelators in the Treatment of Parkinson’s DiseaseNeurochemical Research, 2021
- Design and evaluation of bi-functional iron chelators for protection of dopaminergic neurons from toxicantsArchives of Toxicology, 2020
- Microglia may compensate for dopaminergic neuron loss in experimental Parkinsonism through selective elimination of glutamatergic synapses from the subthalamic nucleusGlia, 2017
- Tumor Necrosis Factor α Is Toxic to Embryonic Mesencephalic Dopamine NeuronsExperimental Neurology, 2001
- MHC class I-restricted killing of neurons by virus-specific CD8+ T lymphocytes is effected through the Fas/FasL, but not the perforin pathwayEuropean Journal of Immunology, 2000